22 November 2024

Howe Street Reporter Title

Tag: biotechnology stocks

  • Three biotech stocks you may have missed

    Three biotech stocks you may have missed

    Kezar Life Sciences Inc. Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends in this market include personalized medicine, drug research, artificial intelligence, big data, and synthetic biology. In total, the biotech market is expected to increase from USD$852.88 billion in 2020,…

  • Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies

    Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies

    Revive Therapeutics (RVV.C) provided an update on their Phase 3 clinical trial for bucillamine for COVID-19 today. Primarily, the update’s about funding and more specifically their recent $23 million financing. The company intends to use the monies to fund their aggressive expansion from14 clinical sites to 50 to meet their enrolment requires for the study…